Serum zinc levels and multiple health outcomes: Implications for zinc-based biomaterials

• Published in: Bioactive materials Vol. 5; no. 2; pp. 410 - 422
• Main Authors: Qu, Xinhua, Yang, Hongtao, Yu, Zhifeng, Jia, Bo, Qiao, Han, Zheng, Yufeng, Dai, Kerong
• Format: Journal Article
• Language: English
• Published: China Elsevier B.V 01.06.2020; KeAi Publishing; KeAi Communications Co., Ltd
• Subjects: Multiple health outcomes; Odds ratio; Serum zinc levels; Zinc-based biomaterials; Serum zinc levels; Odds ratio; Multiple health outcomes; Zinc-based biomaterials
• ISSN: 2452-199X; 2452-199X
• DOI: 10.1016/j.bioactmat.2020.03.006

Zinc-based biomaterials, including biodegradable metal, nanoparticles, and coatings used in medical implants release zinc ions that may increase the whole-body and serum zinc concentrations. The impact of serum zinc concentrations on major health outcomes can provide insights for device design and clinical transformation of zinc-based biomaterials. This nationally representative cross-sectional study enrolled participants from the National Health and Nutrition Examination Survey (NHANES, 2011-2014) including 3607 participants. Using unadjusted and multivariate-adjusted logistic regression analyses, two-piecewise linear regression model with a smoothing function and threshold level analysis, we evaluated the associations between elevated serum zinc levels and major health outcomes. Elevated serum zinc levels were significantly associated with an increase in total spine and total femur bone mineral density (BMD). Every 10 μg/dL increase was associated with a 1.12-fold increase in diabetes mellitus (DM) and 1.23-fold and 1.29-fold increase in cardiovascular diseases (CVD) and coronary heart disease (CHD), in participants with serum zinc levels ≥ 100 μg/dL. It had no significant linear or nonlinear associations with risk of fractures, congestive heart failure, heart attack, thyroid disease, arthritis, osteoarthritis, rheumatoid arthritis, dyslipidemia and cancer. Serum zinc levels are significantly associated with increased BMD in the total spine and total femur, and risk of DM, and CVD/CHD among participants with serum zinc levels ≥100 μg/dL. [Display omitted] •The impact of serum zinc levels on major health outcomes can provide insights for zinc-based biomaterials.•Serum zinc levels are significantly associated with increased BMD in the total spine and total femur.•Serum zinc levels are associated risk of DM, and CHD among participants with serum zinc levels ≥100 μg/dL.